Intrapericardial fibrinolysis with streptokinase in a case of purulent pericarditis;Intraperikardiale Fibrinolyse als therapeutische Option bei der Perikarditis purulenta

Deutsche Medizinische Wochenschrift

Volumn 128, Issue 43, 2003, Pages 2248-2250

  Zimmermann, C ^a,b   Braun, B ^a   Hust, M H ^a  

^a Klinikum am Steinenberg   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DICLOFENAC; FIBRINOLYTIC AGENT; METOPROLOL; PIPERACILLIN; PROTEIN C; ROXITHROMYCIN; STREPTOKINASE; SULBACTAM;

ADULT; ARTICLE; CANCER REGRESSION; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG EFFICACY; FIBRINOLYSIS; HODGKIN DISEASE; HUMAN; MALE; NONHUMAN; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PERICARDITIS; PERICARDIUM; PNEUMONIA; PROTEIN C DEFICIENCY; PUS; RESPIRATORY TRACT INFECTION; THORAX PAIN; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

ADULT; FIBRINOLYSIS; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRALESIONAL; MALE; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PERICARDITIS; PNEUMONIA; RADIOGRAPHY, THORACIC; STREPTOKINASE;

EID: 0242270002     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-43099     Document Type: Article

References (16)

1. Berglin E, Ekroth R, Teger-Nilsson AC, William-Olsson G. Intrapleural instillation of streptokinase: Effects on systemic fibrinolysis. Thorac Cardiovasc Surg 1981; 29: 124-126
2. Bridgman PG. Failure of intrapericardial streptokinase in purulent pericarditis. Intensive Care Med 2001; 27: 942
3. Cakir O, Gurkan F, Balci AE, Eren N, Dikici B. Purulent pericarditis in childhood: ten years of experience. J Pediatr Surg 2002; 37: 1404-1408
4. Chin NK, Lim TK. Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions. Chest 1997; 111: 275-279
5. Defouiolloy C, Meyer G, Slama M et al. Intrapericardial fibrinolysis: a useful treatment in the management of purulent pericarditis. Intensive Care Med 1997; 23: 117-118
6. Godley PJ, Bell RC. Major hemorrhage following administration of intrapleural streptokinase. Chest 1984; 86: 486-487
7. Juneja R, Kothari SS, Saxena A, Sharma R, Joshi A. Intrapericardial streptokinase in purulent pericarditis. Arch Dis Child 1999; 80: 275-277
8. Leak LV, Ferrans VJ, Cohen SR, Eidboo EE, Jones M. Animal model of acute pericarditis and its progression to pericardial fibrosis and adhesions: ultrastructural studies. Am J Anat 1987; 180: 373-390
9. Lee HS. How safe is the readministration of streptokinase? Drug Saf 1995; 13: 79-80
10. Mann-Segal DDM, Shanahan EA, Jones B, Ramasamy D. Purulent pericarditis: rediscovery of an old remedy. J Thorac Cardiovasc Surg 1996; 111: 487-488
11. Pan HL, Liu J, Zhang YD. Effect of intrapericardial urokinase on experimental constrictive pericarditis. J Am Coll Cardiol 1994; 24: 46A
12. Roy BB. Purulent pericarditis treated with streptokinase-streptodornase. J Indian Med Assoc 1954; 24: 264-265
13. Tillett WS, Sherry S. The effect in patients of streptococcal fibinolysin and streptococcal desoxyribonuclease on fibrinous, purulent, and sanguinous pleural exsudations. J Clin Invest 1949; 28: 173-190
14. Ustunsoy H, Celkan MA, Sivrikoz MC, Kazaz H, Kilinc M. Intrapericardial fibrinolytic therapy in purulent pericarditis. Eur J Cardiothorac Surg 2002; 22: 373-376
15. Winkler WB, Karnik R, Slany J. Treatment of exudative fibrinous pericarditis with intrapercardial urokinase. Lancet 1994; 344: 1541-1542
16. Wright LT, Smith DH, Rothmann M, Metzger WI, Quash ET. Use of streptokinase-dornase in certain surgical condition. J Int Coll Surg 1951; 15: 286-298